meglitinide has been researched along with Diabetic Angiopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronow, WS; Horblitt, A; Jolly, G; Sanaani, A; Yandrapalli, S | 1 |
| Ishibashi, S | 1 |
| Fisman, EZ; Motro, M; Tenenbaum, A | 1 |
3 review(s) available for meglitinide and Diabetic Angiopathies
| Article | Year |
|---|---|
Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
Topics: Benzamides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Randomized Controlled Trials as Topic; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones | 2017 |
[Management of blood glucose--target of the management and its practice].
Topics: Benzamides; Blood Glucose; Combined Modality Therapy; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diet, Reducing; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Life Style; Obesity; Postprandial Period; Sulfonylurea Compounds; Thiazolidinediones | 2006 |
Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
Topics: Benzamides; Biguanides; Coronary Disease; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2008 |